AbCellera Biologics Inc vs SiTime Corporation — how do they compare? AbCellera Biologics Inc trades at $9.1 (market cap $2.99B), while SiTime Corporation trades at $683 (market cap $20.05B). The key difference: SiTime Corporation is far larger — about 6.7× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals.
| ABCL | SITM | |
|---|---|---|
Market Cap | $2.99B | $20.05B |
Sector | Health | Technology |
52-Week High | $9.76 | $901.60 |
52-Week Low | $2.78 | $212.77 |
Enterprise Value | $2.58B | $19.45B |
Trailing returns across standard periods
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →